CVR number 43083627
Industry 75.0000 Veterinary activities

Din Dyreklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 3.2% 2.1%  
Credit score (0-100)  0 0 0 56 66  
Credit rating  N/A N/A N/A BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.1  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 2,147 2,730  
EBITDA  0.0 0.0 0.0 698 745  
EBIT  0.0 0.0 0.0 471 550  
Pre-tax profit (PTP)  0.0 0.0 0.0 429.1 523.1  
Net earnings  0.0 0.0 0.0 331.7 451.4  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 429 523  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 745 551  
Shareholders equity total  0.0 0.0 0.0 372 823  
Interest-bearing liabilities  0.0 0.0 0.0 345 117  
Balance sheet total (assets)  0.0 0.0 0.0 1,977 2,183  
Net Debt  0.0 0.0 0.0 -655 -1,184  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 2,147 2,730  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 27.2%  
Employees  0 0 0 2 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 1,977 2,183  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 10.4%  
Added value  0.0 0.0 0.0 471.4 744.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 518 -389  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 22.0% 20.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 23.8% 26.6%  
ROI %  0.0% 0.0% 0.0% 38.9% 43.7%  
ROE %  0.0% 0.0% 0.0% 89.2% 75.6%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 0.0% 18.8% 37.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -93.8% -159.0%  
Gearing %  0.0% 0.0% 0.0% 92.7% 14.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 24.5% 12.8%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 0.0 0.9 1.4  
Current Ratio  0.0 0.0 0.0 1.1 1.6  
Cash and cash equivalent  0.0 0.0 0.0 999.3 1,301.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 71.3 599.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 236 186  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 349 186  
EBIT / employee  0 0 0 236 138  
Net earnings / employee  0 0 0 166 113